Identification 0 14 0 14 O
of 15 17 15 17 O
any 18 21 18 21 O
of 22 24 22 24 O
the 25 28 25 28 O
following 29 38 29 38 O
structural 39 49 39 49 O
lesions 50 57 50 57 O
considered 58 68 58 68 O
causal 69 75 69 75 O
for 76 79 76 79 O
CHB 80 83 80 83 B-chronic_disease
, 83 84 83 84 O
i.e. 85 89 85 89 O
, 89 90 89 90 O
those 91 96 91 96 O
that 97 101 97 101 O
could 102 107 102 107 O
account 108 115 108 115 O
for 116 119 116 119 O
block 120 125 120 125 O
because 126 133 126 133 O
of 134 136 134 136 O
fibrous 137 144 137 144 O
disruption 145 155 145 155 O
between 156 163 156 163 O
the 164 167 164 167 O
atrium 168 174 168 174 O
and 175 178 175 178 O
AV 179 181 179 181 O
node 182 186 182 186 O
or 187 189 187 189 O
due 190 193 190 193 O
to 194 196 194 196 O
absence 197 204 197 204 O
of 205 207 205 207 O
the 208 211 208 211 O
penetrating 212 223 212 223 O
bundles 224 231 224 231 O
of 232 234 232 234 O
the 235 238 235 238 O
AV 239 241 239 241 O
node 242 246 242 246 O

Intrauterine 0 12 247 259 B-clinical_variable
pregnancy 13 22 260 269 I-clinical_variable
≤10 23 26 270 273 O
weeks 27 32 274 279 I-upper_bound

L 0 1 280 281 B-chronic_disease
- 1 2 281 282 I-chronic_disease
transposition 2 15 282 295 I-chronic_disease
of 16 18 296 298 I-chronic_disease
the 19 22 299 302 I-chronic_disease
great 23 28 303 308 I-chronic_disease
arteries 29 37 309 317 I-chronic_disease

Mother 0 6 318 324 O
is 7 9 325 327 O
taking 10 16 328 334 O
any 17 20 335 338 O
glucocorticoids 21 36 339 354 B-treatment
. 36 37 354 355 O
Although 38 46 356 364 O
unlikely 47 55 365 373 O
to 56 58 374 376 O
be 59 61 377 379 O
preventative 62 74 380 392 O
, 74 75 392 393 O
the 76 79 394 397 O
use 80 83 398 401 O
of 84 86 402 404 O
steroids 87 95 405 413 B-treatment
may 96 99 414 417 O
confound 100 108 418 426 O
the 109 112 427 430 O
interpretation 113 127 431 445 O
of 128 130 446 448 O
results 131 138 449 456 O
. 138 139 456 457 O
The 140 143 458 461 O
final 144 149 462 467 O
point 150 155 468 473 O
of 156 158 474 476 O
intense 159 166 477 484 O
discussion 167 177 485 495 O
centered 178 186 496 504 O
around 187 193 505 511 O
whether 194 201 512 519 O
another 202 209 520 527 O
exclusion 210 219 528 537 O
should 220 226 538 544 O
be 227 229 545 547 O
the 230 233 548 551 O
use 234 237 552 555 O
of 238 240 556 558 O
HCQ 241 244 559 562 B-treatment
in 245 247 563 565 O
the 248 251 566 569 O
first 252 257 570 575 O
pregnancy 258 267 576 585 B-pregnancy
in 268 270 586 588 O
which 271 276 589 594 O
CHB 277 280 595 598 B-chronic_disease
occurred 281 289 599 607 O
. 289 290 607 608 O
While 291 296 609 614 O
one 297 300 615 618 O
could 301 306 619 624 O
argue 307 312 625 630 O
that 313 317 631 635 O
in 318 320 636 638 O
these 321 326 639 644 O
mothers 327 334 645 652 O
HCQ 335 338 653 656 O
was 339 342 657 660 O
not 343 346 661 664 O
effective 347 356 665 674 O
and 357 360 675 678 O
perhaps 361 368 679 686 O
will 369 373 687 691 O
not 374 377 692 695 O
be 378 380 696 698 O
again 381 386 699 704 O
, 386 387 704 705 O
this 388 392 706 710 O
assumption 393 403 711 721 O
remains 404 411 722 729 O
speculative 412 423 730 741 O
and 424 427 742 745 O
thus 428 432 746 750 O
prior 433 438 751 756 O
absence 439 446 757 764 O
of 447 449 765 767 O
efficacy 450 458 768 776 O
of 459 461 777 779 O
HCQ 462 465 780 783 O
will 466 470 784 788 O
not 471 474 789 792 O
constitute 475 485 793 803 O
an 486 488 804 806 O
exclusion 489 498 807 816 O
criteria 499 507 817 825 O

Mother 0 6 826 832 O
may 7 10 833 836 O
be 11 13 837 839 O
asymptomatic 14 26 840 852 O
, 26 27 852 853 O
or 28 30 854 856 O
have 31 35 857 861 O
a 36 37 862 863 O
rheumatic 38 47 864 873 B-chronic_disease
disease 48 55 874 881 I-chronic_disease
such 56 60 882 886 O
as 61 63 887 889 O
SLE 64 67 890 893 B-chronic_disease
or 68 70 894 896 O
SS 71 73 897 899 B-chronic_disease
. 73 74 899 900 O
Maternal 75 83 901 909 O
health 84 90 910 916 O
status 91 97 917 923 O
has 98 101 924 927 O
not 102 105 928 931 O
been 106 110 932 936 O
considered 111 121 937 947 O
an 122 124 948 950 O
influence 125 134 951 960 O
on 135 137 961 963 O
the 138 141 964 967 O
development 142 153 968 979 O
of 154 156 980 982 O
CHB 157 160 983 986 B-chronic_disease

Mother 0 6 987 993 O
may 7 10 994 997 O
be 11 13 998 1000 O
taking 14 20 1001 1007 O
≤20 21 24 1008 1011 O
mg 25 27 1012 1014 I-upper_bound
prednisone 28 38 1015 1025 B-clinical_variable
because 39 46 1026 1033 O
, 46 47 1033 1034 O
in 48 50 1035 1037 O
our 51 54 1038 1041 O
experience 55 65 1042 1052 O
, 65 66 1052 1053 O
CHB 67 70 1054 1057 O
has 71 74 1058 1061 O
developed 75 84 1062 1071 O
in 85 87 1072 1074 O
the 88 91 1075 1078 O
presence 92 100 1079 1087 O
of 101 103 1088 1090 O
this 104 108 1091 1095 O
dose 109 113 1096 1100 O

Mother 0 6 1101 1107 O
may 7 10 1108 1111 O
or 11 13 1112 1114 O
may 14 17 1115 1118 O
not 18 21 1119 1122 O
already 22 29 1123 1130 O
be 30 32 1131 1133 O
taking 33 39 1134 1140 O
HCQ 40 43 1141 1144 B-treatment
. 43 44 1144 1145 I-treatment
This 45 49 1146 1150 O
latter 50 56 1151 1157 O
point 57 62 1158 1163 O
was 63 66 1164 1167 O
discussed 67 76 1168 1177 O
with 77 81 1178 1182 O
Dr. 82 85 1183 1186 O
Nathalie 86 94 1187 1195 O
Costedoat 95 104 1196 1205 O
- 104 105 1205 1206 O
Chalumeau 105 114 1206 1215 O
, 114 115 1215 1216 O
who 116 119 1217 1220 O
has 120 123 1221 1224 O
published 124 133 1225 1234 O
extensively 134 145 1235 1246 O
on 146 148 1247 1249 O
measurement 149 160 1250 1261 O
of 161 163 1262 1264 O
HCQ 164 167 1265 1268 O
. 167 168 1268 1269 O
While 169 174 1270 1275 O
it 175 177 1276 1278 O
might 178 183 1279 1284 O
be 184 186 1285 1287 O
optimal 187 194 1288 1295 O
for 195 198 1296 1299 O
the 199 202 1300 1303 O
mothers 203 210 1304 1311 O
anticipating 211 223 1312 1324 O
enrollment 224 234 1325 1335 O
in 235 237 1336 1338 O
the 238 241 1339 1342 O
study 242 247 1343 1348 O
to 248 250 1349 1351 O
all 251 254 1352 1355 O
have 255 259 1356 1360 O
been 260 264 1361 1365 O
on 265 267 1366 1368 O
HCQ 268 271 1369 1372 O
prior 272 277 1373 1378 O
to 278 280 1379 1381 O
conception 281 291 1382 1392 O
, 291 292 1392 1393 O
this 293 297 1394 1398 O
is 298 300 1399 1401 O
impractical 301 312 1402 1413 O
. 312 313 1413 1414 O
Some 314 318 1415 1419 O
may 319 322 1420 1423 O
never 323 328 1424 1429 O
achieve 329 336 1430 1437 O
pregnancy 337 346 1438 1447 B-pregnancy
and 347 350 1448 1451 O
not 351 354 1452 1455 O
want 355 359 1456 1460 O
to 360 362 1461 1463 O
take 363 367 1464 1468 O
HCQ 368 371 1469 1472 O
unless 372 378 1473 1479 O
they 379 383 1480 1484 O
conceive 384 392 1485 1493 O
( 393 394 1494 1495 O
especially 394 404 1495 1505 O
those 405 410 1506 1511 O
asymptomatic 411 423 1512 1524 O
) 423 424 1524 1525 O
. 424 425 1525 1526 O
On 426 428 1527 1529 O
the 429 432 1530 1533 O
other 433 438 1534 1539 O
hand 439 443 1540 1544 O
, 443 444 1544 1545 O
women 445 450 1546 1551 B-gender
with 451 455 1552 1556 O
SLE 456 459 1557 1560 O
are 460 463 1561 1564 O
likely 464 470 1565 1571 O
to 471 473 1572 1574 O
already 474 481 1575 1582 O
be 482 484 1583 1585 O
on 485 487 1586 1588 O
HCQ 488 491 1589 1592 O
and 492 495 1593 1596 O
it 496 498 1597 1599 O
would 499 504 1600 1605 O
limit 505 510 1606 1611 O
enrollment 511 521 1612 1622 O
to 522 524 1623 1625 O
exclude 525 532 1626 1633 O
these 533 538 1634 1639 O
patients 539 547 1640 1648 O
if 548 550 1649 1651 O
all 551 554 1652 1655 O
must 555 559 1656 1660 O
initiate 560 568 1661 1669 O
HCQ 569 572 1670 1673 O
only 573 577 1674 1678 O
at 578 580 1679 1681 O
enrollment 581 591 1682 1692 O
in 592 594 1693 1695 O
the 595 598 1696 1699 O
first 599 604 1700 1705 O
trimester 605 614 1706 1715 O
. 614 615 1715 1716 O
Although 616 624 1717 1725 O
the 625 628 1726 1729 O
accepted 629 637 1730 1738 O
dogma 638 643 1739 1744 O
is 644 646 1745 1747 O
that 647 651 1748 1752 O
HCQ 652 655 1753 1756 O
requires 656 664 1757 1765 O
several 665 672 1766 1773 O
months 673 679 1774 1780 O
for 680 683 1781 1784 O
maximal 684 691 1785 1792 O
efficacy 692 700 1793 1801 O
in 701 703 1802 1804 O
treating 704 712 1805 1813 O
rheumatic 713 722 1814 1823 B-chronic_disease
disease 723 730 1824 1831 I-chronic_disease
, 730 731 1831 1832 O
it 732 734 1833 1835 O
is 735 737 1836 1838 O
unknown 738 745 1839 1846 O
whether 746 753 1847 1854 O
this 754 758 1855 1859 O
would 759 764 1860 1865 O
apply 765 770 1866 1871 O
to 771 773 1872 1874 O
transplacental 774 788 1875 1889 O
passage 789 796 1890 1897 O
or 797 799 1898 1900 O
fetal 800 805 1901 1906 O
levels 806 812 1907 1913 O
( 813 814 1914 1915 O
which 814 819 1915 1920 O
are 820 823 1921 1924 O
impossible 824 834 1925 1935 O
to 835 837 1936 1938 O
measure 838 845 1939 1946 O
) 845 846 1946 1947 O
. 846 847 1947 1948 O
Dr. 848 851 1949 1952 O
Costedoat 852 861 1953 1962 O
- 861 862 1962 1963 O
Chalumeau 862 871 1963 1972 O
suggests 872 880 1973 1981 O
that 881 885 1982 1986 O
HCQ 886 889 1987 1990 O
is 890 892 1991 1993 O
probably 893 901 1994 2002 O
a 902 903 2003 2004 O
three 904 909 2005 2010 O
compartment 910 921 2011 2022 O
model 922 927 2023 2028 O
which 928 933 2029 2034 O
includes 934 942 2035 2043 O
the 943 946 2044 2047 O
circulation 947 958 2048 2059 O
, 958 959 2059 2060 O
tissues 960 967 2061 2068 O
and 968 971 2069 2072 O
cells 972 977 2073 2078 O
. 977 978 2078 2079 O
In 979 981 2080 2082 O
the 982 985 2083 2086 O
circulation 986 997 2087 2098 O
, 997 998 2098 2099 O
the 999 1002 2100 2103 O
half 1003 1007 2104 2108 O
life 1008 1012 2109 2113 O
is 1013 1015 2114 2116 O
approximately 1016 1029 2117 2130 O
7 1030 1031 2131 2132 O
days 1032 1036 2133 2137 O
and 1037 1040 2138 2141 O
in 1041 1043 2142 2144 O
the 1044 1047 2145 2148 O
tissues 1048 1055 2149 2156 O
, 1055 1056 2156 2157 O
it 1057 1059 2158 2160 O
is 1060 1062 2161 2163 O
40 1063 1065 2164 2166 B-lower_bound
days 1066 1070 2167 2171 O
. 1070 1071 2171 2172 O
In 1072 1074 2173 2175 O
Dr. 1075 1078 2176 2179 O
Costedoat 1079 1088 2180 2189 O
- 1088 1089 2189 2190 O
Chalumeau 1089 1098 2190 2199 O
's 1098 1100 2199 2201 O
experience 1101 1111 2202 2212 O
, 1111 1112 2212 2213 O
steady 1113 1119 2214 2220 O
state 1120 1125 2221 2226 O
blood 1126 1131 2227 2232 O
levels 1132 1138 2233 2239 O
of 1139 1141 2240 2242 O
HCQ 1142 1145 2243 2246 O
are 1146 1149 2247 2250 O
achieved 1150 1158 2251 2259 O
in 1159 1161 2260 2262 O
4 1162 1163 2263 2264 O
- 1163 1164 2264 2265 O
6 1164 1165 2265 2266 B-upper_bound
weeks 1166 1171 2267 2272 I-upper_bound
. 1171 1172 2272 2273 O
Thus 1173 1177 2274 2278 O
, 1177 1178 2278 2279 O
dosing 1179 1185 2280 2286 O
the 1186 1189 2287 2290 O
mother 1190 1196 2291 2297 O
no 1197 1199 2298 2300 O
later 1200 1205 2301 2306 O
than 1206 1210 2307 2311 O
10 1211 1213 2312 2314 B-upper_bound
weeks 1214 1219 2315 2320 I-upper_bound
gestation 1220 1229 2321 2330 O
should 1230 1236 2331 2337 O
provide 1237 1244 2338 2345 O
sufficient 1245 1255 2346 2356 O
fetal 1256 1261 2357 2362 O
exposure 1262 1270 2363 2371 O
before 1271 1277 2372 2378 O
the 1278 1281 2379 2382 O
vulnerable 1282 1292 2383 2393 O
period 1293 1299 2394 2400 O
of 1300 1302 2401 2403 O
CHB 1303 1306 2404 2407 O
which 1307 1312 2408 2413 O
is 1313 1315 2414 2416 O
generally 1316 1325 2417 2426 O
accepted 1326 1334 2427 2435 O
to 1335 1337 2436 2438 O
span 1338 1342 2439 2443 O
18 1343 1345 2444 2446 B-lower_bound
- 1345 1346 2446 2447 O
24 1346 1348 2447 2449 B-upper_bound
wks 1349 1352 2450 2453 I-upper_bound
. 1352 1353 2453 2454 O
Furthermore 1354 1365 2455 2466 O
, 1365 1366 2466 2467 O
the 1367 1370 2468 2471 O
placenta 1371 1379 2472 2480 O
has 1380 1383 2481 2484 O
to 1384 1386 2485 2487 O
be 1387 1389 2488 2490 O
formed 1390 1396 2491 2497 O
for 1397 1400 2498 2501 O
HCQ 1401 1404 2502 2505 O
to 1405 1407 2506 2508 O
gain 1408 1412 2509 2513 O
access 1413 1419 2514 2520 O
to 1420 1422 2521 2523 O
the 1423 1426 2524 2527 O
fetus 1427 1432 2528 2533 O
and 1433 1436 2534 2537 O
it 1437 1439 2538 2540 O
may 1440 1443 2541 2544 O
be 1444 1446 2545 2547 O
effective 1447 1456 2548 2557 O
quickly 1457 1464 2558 2565 O
for 1465 1468 2566 2569 O
the 1469 1472 2570 2573 O
biology 1473 1480 2574 2581 O
we 1481 1483 2582 2584 O
are 1484 1487 2585 2588 O
considering 1488 1499 2589 2600 O

Mothers 0 7 2601 2608 O
must 8 12 2609 2613 O
have 13 17 2614 2618 O
a 18 19 2619 2620 O
previous 20 28 2621 2629 O
child 29 34 2630 2635 O
with 35 39 2636 2640 O
cardiac 40 47 2641 2648 B-chronic_disease
NL 48 50 2649 2651 I-chronic_disease
, 50 51 2651 2652 O
defined 52 59 2653 2660 O
herein 60 66 2661 2667 O
as 67 69 2668 2670 O
: 69 70 2670 2671 O
the 71 74 2672 2675 O
presence 75 83 2676 2684 O
of 84 86 2685 2687 O
heart 87 92 2688 2693 O
block 93 98 2694 2699 O
( 99 100 2700 2701 O
1st 100 103 2701 2704 O
, 103 104 2704 2705 O
2nd 105 108 2706 2709 O
, 108 109 2709 2710 O
or 110 112 2711 2713 O
3rd 113 116 2714 2717 O
degree 117 123 2718 2724 O
) 123 124 2724 2725 O
documented 125 135 2726 2736 O
by 136 138 2737 2739 O
electrocardiogram 139 156 2740 2757 B-treatment
( 157 158 2758 2759 I-treatment
EKG 158 161 2759 2762 I-treatment
) 161 162 2762 2763 I-treatment
, 162 163 2763 2764 O
echocardiogram 164 178 2765 2779 B-treatment
, 178 179 2779 2780 O
pacemaker 180 189 2781 2790 B-treatment
, 189 190 2790 2791 O
or 191 193 2792 2794 O
statement 194 203 2795 2804 O
in 204 206 2805 2807 O
the 207 210 2808 2811 O
medical 211 218 2812 2819 O
record 219 225 2820 2826 O
, 225 226 2826 2827 O
and/or 227 233 2828 2834 O
; 233 234 2834 2835 O
presence 235 243 2836 2844 O
of 244 246 2845 2847 O
cardiac 247 254 2848 2855 O
injury 255 261 2856 2862 O
, 261 262 2862 2863 O
which 263 268 2864 2869 O
specifically 269 281 2870 2882 O
includes 282 290 2883 2891 O
autopsy 291 298 2892 2899 O
evidence 299 307 2900 2908 O
of 308 310 2909 2911 O
a 311 312 2912 2913 O
mononuclear 313 324 2914 2925 O
infiltrate 325 335 2926 2936 O
in 336 338 2937 2939 O
the 339 342 2940 2943 O
endocardium 343 354 2944 2955 O
, 354 355 2955 2956 O
myocardium 356 366 2957 2967 O
, 366 367 2967 2968 O
and 368 371 2969 2972 O
pericardium 372 383 2973 2984 O
and/or 384 390 2985 2991 O
EFE 391 394 2992 2995 O
on 395 397 2996 2998 O
echocardiogram 398 412 2999 3013 O
always 413 419 3014 3020 O
associated 420 430 3021 3031 O
with 431 435 3032 3036 O
cardiac 436 443 3037 3044 B-chronic_disease
dysfunction 444 455 3045 3056 I-chronic_disease
. 455 456 3056 3057 O
In 457 459 3058 3060 O
PITCH 460 465 3061 3066 O
, 465 466 3066 3067 O
we 467 469 3068 3070 O
included 470 478 3071 3079 O
women 479 484 3080 3085 B-gender
with 485 489 3086 3090 O
a 490 491 3091 3092 O
prior 492 497 3093 3098 O
child 498 503 3099 3104 O
with 504 508 3105 3109 O
rash 509 513 3110 3114 O
; 513 514 3114 3115 O
however 515 522 3116 3123 O
, 522 523 3123 3124 O
recent 524 530 3125 3131 O
data 531 535 3132 3136 O
generated 536 545 3137 3146 O
from 546 550 3147 3151 O
the 551 554 3152 3155 O
RRNL 555 559 3156 3160 O
suggest 560 567 3161 3168 O
that 568 572 3169 3173 O
recurrence 573 583 3174 3184 O
of 584 586 3185 3187 O
CHB 587 590 3188 3191 O
following 591 600 3192 3201 O
rash 601 605 3202 3206 O
is 606 608 3207 3209 O
11 609 611 3210 3212 O
% 611 612 3212 3213 O
, 612 613 3213 3214 O
not 614 617 3215 3218 O
18 618 620 3219 3221 O
% 620 621 3221 3222 O
[ 622 623 3223 3224 O
34 623 625 3224 3226 O
] 625 626 3226 3227 O
. 626 627 3227 3228 O
Thus 628 632 3229 3233 O
, 632 633 3233 3234 O
inclusion 634 643 3235 3244 O
of 644 646 3245 3247 O
previous 647 655 3248 3256 O
rash 656 660 3257 3261 O
could 661 666 3262 3267 O
lead 667 671 3268 3272 O
to 672 674 3273 3275 O
a 675 676 3276 3277 O
falsely 677 684 3278 3285 O
lowered 685 692 3286 3293 O
recurrence 693 703 3294 3304 O
rate 704 708 3305 3309 O
, 708 709 3309 3310 O
and 710 713 3311 3314 O
will 714 718 3315 3319 O
therefore 719 728 3320 3329 O
be 729 731 3330 3332 O
excluded 732 740 3333 3341 O

Mothers 0 7 3342 3349 O
must 8 12 3350 3354 O
have 13 17 3355 3359 O
anti 18 22 3360 3364 O
- 22 23 3364 3365 O
Ro 23 25 3365 3367 O
and/or 26 32 3368 3374 O
anti 33 37 3375 3379 O
- 37 38 3379 3380 O
La 38 40 3380 3382 O
Ab 41 43 3383 3385 O
documented 44 54 3386 3396 O
in 55 57 3397 3399 O
the 58 61 3400 3403 O
NYU 62 65 3404 3407 O
immunology 66 76 3408 3418 O
laboratory 77 87 3419 3429 O
( 88 89 3430 3431 O
CLIA 89 93 3431 3435 O
- 93 94 3435 3436 O
approved 94 102 3436 3444 O
) 102 103 3444 3445 O
, 103 104 3445 3446 O
which 105 110 3447 3452 O
utilizes 111 119 3453 3461 O
an 120 122 3462 3464 O
ELISA 123 128 3465 3470 O
as 129 131 3471 3473 O
well 132 136 3474 3478 O
as 137 139 3479 3481 O
reactivity 140 150 3482 3492 O
on 151 153 3493 3495 O
ELISA 154 159 3496 3501 O
to 160 162 3502 3504 O
at 163 165 3505 3507 O
least 166 171 3508 3513 O
one 172 175 3514 3517 B-lower_bound
of 176 178 3518 3520 O
three 179 184 3521 3526 B-upper_bound
recombinant 185 196 3527 3538 O
antigens 197 205 3539 3547 O
( 206 207 3548 3549 O
48La 207 211 3549 3553 O
, 211 212 3553 3554 O
52Ro 213 217 3555 3559 O
, 217 218 3559 3560 O
60Ro 219 223 3561 3565 O
, 223 224 3565 3566 O
JB 225 227 3567 3569 O
laboratory 228 238 3570 3580 O
) 238 239 3580 3581 O

atrioventricular 0 16 3582 3598 B-chronic_disease
septal 17 23 3599 3605 I-chronic_disease
defects 24 31 3606 3613 I-chronic_disease

developmental 0 13 3614 3627 O
tricuspid 14 23 3628 3637 B-chronic_disease
valve 24 29 3638 3643 I-chronic_disease
disease 30 37 3644 3651 I-chronic_disease

heterotaxia 0 11 3652 3663 B-chronic_disease

single 0 6 3664 3670 B-chronic_disease
ventricle 7 16 3671 3680 I-chronic_disease

